Oscar Health (OSCR) Long-Term Investments (2020 - 2026)

Oscar Health's Long-Term Investments history runs 7 years deep, the most recent figure standing at $3.3 billion for Q1 2026.

• Quarterly Long-Term Investments rose 10417.31% year-over-year to $3.3 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 billion (up 10417.31% YoY) and the FY2025 annual result came in at $33.0 million, down 98.65% from the prior year.
• Long-Term Investments was $3.3 billion for Q1 2026 at Oscar Health, up from $33.0 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $3.3 billion in Q1 2026 and bottomed at $27.2 million in Q1 2022.
• A 5-year average of $705.9 million and a median of $196.5 million in 2022 frame the typical range for Long-Term Investments.
• Annual changes were most pronounced in 2025 — Long-Term Investments slumped 98.65% — and 2026, when it surged 10417.31%.
• Oscar Health's Long-Term Investments stood at $222.9 million in 2022, then jumped by 63.88% to $365.3 million in 2023, then jumped by 567.85% to $2.4 billion in 2024, then slumped by 98.65% to $33.0 million in 2025, then jumped by 9797.78% to $3.3 billion in 2026.
• Business Quant data shows OSCR's Long-Term Investments at $3.3 billion in Q1 2026, $33.0 million in Q4 2025, and $27.9 million in Q3 2025.